Skip to main content

Table 4 Association between healthcare vulnerable areas of pancreatic cancer patients and pancreatic cancer treatment

From: Healthcare vulnerability disparities in pancreatic cancer treatment and mortality using the Korean National Sample Cohort: a retrospective cohort study

Variables

Pancreatic Cancer Treatment

No

treatment

Surgery

Chemotherapy

OR a

95% CI

 

OR b

95% CI

OR b

95% CI

Healthcare Vulnerability

 Vulnerable region

0.70

(0.52

-

0.94)

 

0.74

(0.50

-

1.11)

0.68

(0.48

-

0.95)

 Non-vulnerable region

1.00

   

1.00

        

Sex

 Male

1.00

   

1.00

        

 Female

0.98

(0.80

-

1.19)

 

1.04

(0.80

-

1.36)

0.94

(0.75

-

1.18)

Age

  < 50

1.00

   

1.00

        

 50–60

1.39

(0.95

-

2.03)

 

1.05

(0.64

-

1.72)

1.65

(1.07

-

2.55)

 60–70

1.43

(1.00

-

2.04)

 

1.15

(0.73

-

1.82)

1.64

(1.09

-

2.47)

 70–80

0.80

(0.56

-

1.14)

 

0.61

(0.38

-

0.97)

0.95

(0.63

-

1.43)

  ≥ 80

0.13

(0.08

-

0.20)

 

0.14

(0.07

-

0.24)

0.12

(0.07

-

0.21)

Household income

 Low

1.00

   

1.00

        

 Mid-low

1.06

(0.80

-

1.41)

 

1.25

(0.85

-

1.83)

0.97

(0.71

-

1.33)

 Mid-high

1.21

(0.93

-

1.58)

 

1.33

(0.92

-

1.92)

1.15

(0.86

-

1.55)

Medical Insurance

 Insurance Coverage(Regional)

1.00

   

1.00

        

 Insurance Coverage(corporate)

1.17

(0.95

-

1.45)

 

1.25

(0.94

-

1.67)

1.13

(0.89

-

1.43)

 Medical Aid

1.35

(0.71

-

2.58)

 

1.10

(0.41

-

2.93)

1.49

(0.73

-

3.03)

Disorder

 No

1.00

   

1.00

        

 Yes

0.71

(0.52

-

0.96)

 

0.86

(0.57

-

1.29)

0.63

(0.43

-

0.90)

CCI

 0

1.00

   

1.00

        

 1–2

1.13

(0.86

-

1.48)

 

1.30

(0.90

-

1.86)

1.04

(0.77

-

1.41)

  ≥ 3

0.51

(0.39

-

0.68)

 

0.55

(0.37

-

0.81)

0.49

(0.36

-

0.68)

  1. OR Odds ratio, CI Confidence interval, CCI Charlson Comorbidity Index
  2. a Results of association between healthcare vulnerability and treatment of pancreatic cancer patients using multiple logistic regression
  3. b Results of association between healthcare vulnerability, surgery, and chemotherapy in pancreatic cancer patients using multinomial logistic regressions